Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02556398 · ClinicalTrials.gov registry record · NA

Use of Mobile-based Technologies to Improve Diabetes Self-management and Postprandial Glucose Control

A NA study of Type 1 Diabetes, sponsored by Joslin Diabetes Center.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT02556398: Completed NA study of Type 1 Diabetes, sponsored by Joslin Diabetes Center.

NCT02556398 is a NA study of Type 1 Diabetes that has completed, run by Joslin Diabetes Center. The registered enrollment target is 35 participants, below the 767-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02556398, a NA study of Type 1 Diabetes, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

The project involve evaluation of a web-based nutrition education program and pilot-testing of a new smartphone app for real-time data logging to identify factors causing glycemic variability.

Primary Outcome

Amount of time spent above \>180 mg/dL on CGM Freestyle Libre readings

Conditions Studied

Interventions

  • BEHAVIORAL Sugar Sleuth

Study Locations (1)

Massachusetts

  • Joslin Diabetes Center - Boston

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2015-09
Est. Completion 2021-01-22
Phase NA
Joslin Diabetes Center

73 total trials

What the finished NCT02556398 record still lists

NCT02556398 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 767-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Sugar Sleuth is the first listed.

NCT02556398 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02556398 about?

NCT02556398 is a clinical study titled "Use of Mobile-based Technologies to Improve Diabetes Self-management and Postprandial Glucose Control". The project involve evaluation of a web-based nutrition education program and pilot-testing of a new smartphone app for real-time data logging to identify factors causing glycemic variability.

What is the current status of trial NCT02556398?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2015-09. Estimated completion is 2021-01-22.

What conditions does trial NCT02556398 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT02556398?

The interventions under investigation include: Sugar Sleuth (BEHAVIORAL).

Who is sponsoring clinical trial NCT02556398?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02556398 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02556398's enrollment target sits among peer trials

35 117th of 198 higher than 82 of 198 other Type 1 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02556398, the US trial registry maintained by the National Library of Medicine. NCT02556398 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.